December 2023, Vol 4, No 4

Presentations cover the history of surgical approaches to biliary tract cancers, neoadjuvant and adjuvant perioperative therapies, transplantation, and advances in surgery technology.

The Cholangiocarcinoma Foundation (CCF) is pleased to announce the 11th Annual Cholangiocarcinoma Foundation Conference in Salt Lake City, UT, April 17-19, 2024.

The 5th annual CCA Summit, held October 19-21, 2023, in Scottsdale, AZ, was a very successful meeting by all measures and has gradually become one of the key scientific meetings in biliary tract cancers.

This CCA News feature aims to provide an ongoing list of US-based clinical trials that are actively recruiting for clinicians to use in discussions with their patients to encourage enrollment.

This year’s Keynote Address touched on wide-ranging topics in the management of cholangiocarcinoma, from recent advances to emerging management strategies.

Expert panelists discussed the benefits and limitations of various radiation regimens.

Session V included a series of presentations on new molecular targets and pathways in cholangiocarcinoma.

The tumor microenvironment, the various types of biomarkers, and the many applications for biomarkers were discussed in this series of presentations.

Many informative and interesting posters covering clinical trials were presented at the CCA Summit. The session featured 3 posters that examined the chemotherapy/immunotherapy landscape, including “Gemcitabine plus cisplatin versus non-gemcitabine and cisplatin regimens as neoadjuvant treatment for cholangiocarcinoma patients prior to liver transplantation: an institution experience.”